Jurnal Lagi
Jurnal Lagi
Jurnal Lagi
Rheumatic Diseases
THIRTEENTH EDITION
Primer on the
Rheumatic Diseases
THIRTEENTH EDITION
Edited by
John H. Klippel, MD
John H. Stone, MD, MPH
Leslie J. Crofford, MD
Patience H. White, MD, MA
John H. Klippel, MD John H. Stone, MD, MPH
President and CEO Associate Physician
Arthritis Foundation Massachusetts General Hospital
Atlanta, GA, USA Deputy Editor for Rheumatology
UpToDate
Leslie J. Crofford, MD Boston, MA, USA
Gloria W. Singletary Professor of
Internal Medicine Patience H. White, MD, MA
Chief, Division of Rheumatology & Chief Public Health Officer
Women’s Health Arthritis Foundation
University of Kentucky Atlanta, GA, USA
Lexington, KY, USA
9 8 7 6 5 4 3 2 1
springer.com
FOREWORD
The 13th edition of the Primer on the Rheumatic Diseases is an extraordinary hand-
book for clinical care. The Primer will educate trainees, update established clini-
cians, and help health care providers from all walks of the profession provide better
care for patients with arthritis and rheumatic diseases.
In achieving these purposes, the Primer continues a tradition of excellence dating
back more than 70 years. The Primer and its precursors have served as a major
learning tool for medical students, house officers, fellows, and allied health profes-
sionals since 1934, when the early publications of the American Committee for the
Control of Rheumatism included the Primer on Rheumatism: Chronic Arthritis in
1934. Since that work, which consisted of a 52-page brochure, the Primer has
evolved into a reference guide of nearly 90 chapters and 4 appendices.
The Primer is designed to provide up-to-date information about the major clini-
cal syndromes seen by primary care physicians, rheumatologists, orthopedic sur-
geons, as well as physician assistants, nurse practitioners, physical and occupational
therapists, and allied health professionals whose expertise contributes to patient
care. Emphasis on the evaluation of the patient, the physical examination including
musculoskeletal signs and symptoms, laboratory and imaging evaluations, and
current and novel therapeutic approaches are essential for all who work in this field.
Arthritis and other rheumatic diseases, which affect more than 46 million Ameri-
cans (including 300,000 children), remain a leading cause of disability and the most
common chronic illness in the United States.
I congratulate the editors on their superb work. In addition, the multiple con-
tributors—many of whom are members of the American College of Rheumatology—
should be thanked for their scholarly contributions to the Primer. Rheumatology
has never been more exciting than it is today, and there is no doubt that the 13th
edition of the Primer reflects this. I join clinicians and patients alike in thanking the
Arthritis Foundation for the continuing achievements of this book.
Michael E. Weinblatt, MD
Professor of Medicine
Harvard Medical School
Brigham and Women’s Hospital
Boston, MA, USA
v
Preface
Students, residents, and fellows interested in learning about the rheumatic diseases
are faced with the daunting challenge of trying to integrate learning about a multi-
tude of fascinating and diverse clinical disorders with an ever-expanding and
complex body of basic science.
This need encapsulates the principal rationale for the major changes in the 13th
edition of The Primer on the Rheumatic Diseases. Although the first part of all
recent editions of The Primer have summarized succinctly the physiology of tissues
and cells that mediate inflammation and musculoskeletal disease, preparation of the
new edition resulted in the identification of two major problems with this “tried-
and-true” formula. First, for readers who really wished to understand the molecular
basis of rheumatic disease to the depth that would facilitate laboratory research and
improve patient care, the initial chapters no longer provided sufficient detail.
Second, for readers seeking an introduction or update within the clinical realm of
rheumatic disorders, the first part of The Primer bore virtually no relation to the
diseases described so engagingly in the rest of the book. In short, in this era of
increasing integration between the basic and clinical sciences, the preliminary
Primer chapters were at risk for becoming simply the pages thumbed through
quickly to get to the good stuff.
Therefore, in the 13th edition, the clinical descriptions that The Primer has
always done best have been augmented by including the clinically relevant basic
science components in the same sections. Thus, for each major rheumatic disease—
for example, rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, and
idiopathic inflammatory myopathies—the chapter describing the clinical and epide-
miological features is accompanied by another chapter devoted to “Pathology and
Pathogenesis.” This second chapter incorporates the appropriate (and updated)
elements from previous Primer chapters entitled “Synovium,” “Articular Carti-
lage,” “The Complement System,” and “Muscle” that are essential to understanding
a particular disease today.
Moreover, this fundamental change in the contents is only the beginning of the
improvements to the 13th edition. Other changes include:
John H. Klippel, MD
John H. Stone, MD, MPH
Leslie J. Crofford, MD
Patience H. White, MD, MA
CONTENTS
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
B. Laboratory Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Kerstin Morehead
ix
x CONTENTS
C. Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
Leena Sharma
C. Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258
Robert A. Terkeltaub
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 703
CONTRIBUTORS
xv
xvi CONTRIBUTORS
Hyon K. Choi, MD, MPH, DrPH, FRCPC Adel G. Fam, MD, FRCP(C), FACP
Associate Professor of Medicine and Mary Pack Arthritis Emeritus Professor of Medicine, Department of Medicine,
Society Chair in Rheumatology, Department of Medicine, Division of Rheumatology, Sunnybrook & Women’s College
Division of Rheumatology, The University of British Health Sciences Centre, University of Toronto, Toronto,
Columbia, Vancouver, British Columbia, Canada Ontario, Canada
Dina Dadabhoy, MD
Dafna D. Gladman, MD, FRCPC
Clinical Lecturer, Department of Internal Medicine, Division
Professor, Department of Medicine/Rheumatology, University
of Rheumatology, University of Michigan, Ann Arbor, MI,
of Toronto; Senior Scientist, Toronto Western Research
USA
Institute; Director, Psoriatic Arthritis Program, University
Health Network, Toronto, Canada
Troy Daniels, DDS, MS
Professor, Schools of Dentistry and Medicine, University of
California, San Francisco, San Francisco, CA, USA Duncan A. Gordon, MD, FRCPC, MACR
Professor, Department of Medicine, University of Toronto;
John C. Davis, Jr., MD, MPH Rheumatologist, University Health Network, Toronto
Associate Professor, Department of Medicine, Division of Western Hospital, Toronto, Ontario, Canada
Rheumatology, University of California San Francisco, San
Francisco, CA, USA Jörg J. Goronzy, MD
Co-Director, Department of Medicine, Kathleen B. and
William J. Didie, MD Mason I. Lowance Center for Human Immunology, Emory
Fellow, Musculoskeletal Imaging, Department of Radiology, University School of Medicine, Atlanta, GA, USA
Johns Hopkins University, Baltimore, MD, USA
Philip J. Hashkes, MD, MSc
Paul Dieppe, MD Head, Section of Pediatric Rheumatology, Department of
Professor, Department of Social Medicine, University of Rheumatic Diseases, Cleveland Clinic Foundation, Cleveland,
Bristol, Bristol, UK OH, USA
C O N T R I B U T O R S x vi i